Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioCorRx Inc. stock logo
BICX
BioCorRx
$0.30
-6.3%
$0.36
$0.26
$1.45
$5.07M0.1110,406 shs330 shs
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.33
-14.8%
$0.35
$0.25
$1.28
$17.03M1.19168,181 shs4.12 million shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.39
+4.4%
$1.07
$0.40
$2.08
$20.71M4.7419,687 shs74,127 shs
PCHM
PharmChem
$3.70
+5.7%
$3.12
$2.85
$4.00
$17.20M0.736,587 shs9,318 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioCorRx Inc. stock logo
BICX
BioCorRx
0.00%-3.57%+4.68%-7.98%-62.50%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00%0.00%0.00%-37.02%-69.34%
Marpai, Inc. stock logo
MRAI
Marpai
0.00%+14.88%+39.00%+45.15%-30.50%
PCHM
PharmChem
0.00%+8.82%+23.33%+8.82%+32.14%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioCorRx Inc. stock logo
BICX
BioCorRx
0.0834 of 5 stars
0.02.00.00.00.01.70.0
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/AN/AN/AN/AN/AN/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/AN/AN/AN/A
PCHM
PharmChem
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioCorRx Inc. stock logo
BICX
BioCorRx
0.00
N/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00
N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
0.00
N/AN/AN/A
PCHM
PharmChem
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioCorRx Inc. stock logo
BICX
BioCorRx
$90K56.33N/AN/A($1.14) per share-0.26
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$29.09M0.59N/AN/A$1.09 per share0.30
Marpai, Inc. stock logo
MRAI
Marpai
$34.87M0.59N/AN/A($1.72) per share-0.81
PCHM
PharmChem
$6.01M2.86N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioCorRx Inc. stock logo
BICX
BioCorRx
-$3.77M-$0.41N/AN/A-11,600.00%N/A-1,074.47%8/11/2025 (Estimated)
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
-$26.08MN/A0.00N/A-75.34%-7.96%-5.49%6/12/2025 (Estimated)
Marpai, Inc. stock logo
MRAI
Marpai
-$28.75M-$1.82N/AN/A-85.70%N/A-100.23%8/5/2025 (Estimated)
PCHM
PharmChem
$850K$0.3212.76N/A23.32%N/AN/A8/5/2025 (Estimated)

Latest BICX, MRAI, ENZ, and PCHM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
BioCorRx Inc. stock logo
BICX
BioCorRx
N/A-$0.06N/A-$0.06N/AN/A
5/9/2025Q1 2025
PCHM
PharmChem
N/A$0.06N/A$0.06N/A$1.58 million
3/31/2025Q4 2024
BioCorRx Inc. stock logo
BICX
BioCorRx
N/A-$0.08N/A-$0.08N/AN/A
3/17/2025Q2 2025
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A-$0.02N/A-$0.03N/A$7.33 million
3/6/2025Q4 2024
PCHM
PharmChem
N/A$0.06N/A$0.06N/A$1.52 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioCorRx Inc. stock logo
BICX
BioCorRx
N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.40123.08%N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/A
PCHM
PharmChem
$0.8021.62%N/A250.00%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioCorRx Inc. stock logo
BICX
BioCorRx
N/A
0.04
0.04
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A
2.55
2.28
Marpai, Inc. stock logo
MRAI
Marpai
N/A
0.82
0.82
PCHM
PharmChem
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
BioCorRx Inc. stock logo
BICX
BioCorRx
N/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
36.90%
Marpai, Inc. stock logo
MRAI
Marpai
49.75%
PCHM
PharmChem
N/A

Insider Ownership

CompanyInsider Ownership
BioCorRx Inc. stock logo
BICX
BioCorRx
21.40%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
11.40%
Marpai, Inc. stock logo
MRAI
Marpai
61.30%
PCHM
PharmChem
17.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
BioCorRx Inc. stock logo
BICX
BioCorRx
316.90 million11.92 millionNot Optionable
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
52052.40 million46.29 millionOptionable
Marpai, Inc. stock logo
MRAI
Marpai
15014.90 million5.61 millionNo Data
PCHM
PharmChem
1704.65 million3.84 millionNot Optionable

Recent News About These Companies

PharmChem considers strategic alternatives
Cedar Creek Partners Q3 2024 Results
Cedar Creek Partners Q2 2024 Results
Getinge AB (publ) (GTN0.F)
PharmChem, Inc. (PCHM)
Filipino Food Month in Qatar
‘Boost PHL food culture, fight food insecurity’
Punjab Chemicals and Crop Protection Ltd (PCHM)
Punjab Chemicals and Crop Protection Ltd

Media Sentiment Over Time

BioCorRx stock logo

BioCorRx OTCMKTS:BICX

$0.30 -0.02 (-6.25%)
As of 05/23/2025 02:37 PM Eastern

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

Enzo Biochem stock logo

Enzo Biochem NYSE:ENZ

$0.32 -0.06 (-14.83%)
Closing price 04/17/2025
Extended Trading
$0.32 0.00 (0.00%)
As of 04/17/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Marpai stock logo

Marpai NASDAQ:MRAI

$1.39 +0.06 (+4.42%)
As of 05/23/2025 03:02 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

PharmChem OTCMKTS:PCHM

$3.70 +0.20 (+5.71%)
As of 05/23/2025 03:27 PM Eastern

PharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.